ONCOCYTE CORP (OCX)

US68235C2061 - Common Stock

3.19  +0.14 (+4.59%)

After market: 2.89 -0.3 (-9.4%)

Full estimates are only available for subscribed users, you can see which data is available below.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2021 2022 2023 2024 2025 2026
Revenue
YoY % growth
2.2M
80.33%		960K
-56.36%		1.503M
56.56%		499.95K
-66.74%
EBITDA
YoY % growth
-47.07M
-62.87%		7.41M
115.74%		-14.826M
-300.08%		-3.535M
76.16%
EBIT
YoY % growth
-51.27M
-75.04%		2.19M
104.27%		-16.506M
-853.70%		-26.431M
-60.13%
Operating Margin
-2,330.45%228.13%-1,098.20%-5,286.77%
EPS
YoY % growth
-0.44
4.35%		-13.20
-2,900.00%		-3.60
72.73%		-2.31
35.91%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q3 / 24 Q4 / 24 Q1 / 25 Q2 / 25 Q3 / 25 Q4 / 25 Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26
EPS
Q2Q % growth		-0.46
43.39%
Revenue
Q2Q % growth		101K
-76.46%
EBITDA
Q2Q % growth		-1.111M
66.64%
EBIT
Q2Q % growth		-5.741M
-22.42%

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q2 2024
Q2Q % growth		 -0.36
66.36%		-0.560.2036.24%
Q1 2024
Q2Q % growth		 -1.13
-382.50%		-0.68-0.45-67.40%
Q4 2023
Q2Q % growth		 -2.12
73.50%		-1.15-0.97-84.61%
Q3 2023
Q2Q % growth		 -0.81
49.38%		-1.020.2120.40%
Q2 2023
Q2Q % growth
Q1 2023
Q2Q % growth
Q4 2022
Q2Q % growth
Q3 2022
Q2Q % growth
Q2 2022
Q2Q % growth
Q1 2022
Q2Q % growth
Q4 2021
Q2Q % growth
Q3 2021
Q2Q % growth
Q2 2021
Q2Q % growth
Q1 2021
Q2Q % growth
Q4 2020
Q2Q % growth
Q3 2020
Q2Q % growth
Q2 2020
Q2Q % growth
Q1 2020
Q2Q % growth
Q4 2019
Q2Q % growth
Q3 2019
Q2Q % growth
Q2 2019
Q2Q % growth
Q1 2019
Q2Q % growth
Q4 2018
Q2Q % growth
Q3 2018
Q2Q % growth
Q2 2018
Q2Q % growth
Q1 2018
Q2Q % growth
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q2 2024
Q2Q % growth		 104K
-77.54%		321.685K-217.685K-67.67%
Q1 2024
Q2Q % growth		 176K
-40.74%		353.5K-177.5K-50.21%
Q4 2023
Q2Q % growth		 314K
16.30%		319.837K-5.837K-1.82%
Q3 2023
Q2Q % growth		 429K
512.86%		315.625K113.375K35.92%
Q2 2023
Q2Q % growth
Q1 2023
Q2Q % growth
Q4 2022
Q2Q % growth
Q3 2022
Q2Q % growth
Q2 2022
Q2Q % growth
Q1 2022
Q2Q % growth
Q4 2021
Q2Q % growth
Q3 2021
Q2Q % growth
Q2 2021
Q2Q % growth
Q1 2021
Q2Q % growth
Q4 2020
Q2Q % growth
Q3 2020
Q2Q % growth
Q2 2020
Q2Q % growth
Q1 2020
Q2Q % growth
Q4 2019
Q2Q % growth
Q3 2019
Q2Q % growth
Q2 2019
Q2Q % growth
Q1 2019
Q2Q % growth
Q4 2018
Q2Q % growth
Q3 2018
Q2Q % growth
Q2 2018
Q2Q % growth
Q1 2018
Q2Q % growth
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS17% 17% 0.2% -16.6%
Revenue-79.23% -79.23% -43.16% -37.54%